Unemployed Could Get Weight Loss Jabs In A Bid To Get Them Back To Work
In plans announced recently by the current health secretary, Wes Streeting, weight loss jabs could be given to unemployed people to help them get back to work.
So far, plans have been unveiled to conduct a “real-world study” investigating how effective weight loss injections could be in enabling obese people to return to work. The five-year trial will take place in Greater Manchester.
What will the study consist of?
Manufacturers of the weight loss injections Mounjaro and Zepbound, Eli Lilly, recently announced a £279 million partnership with the UK government to tackle public health challenges including obesity.
The trial will use tirzepatide, the active ingredient in Mounjaro and Zepbound, and will be run by Health Innovation Manchester, alongside Eli Lilly, the University of Manchester, and NorthWest EHealth.
Although it’s not yet known who the participants in the trial will be, it is believed that around 3000 people in the Greater Manchester area will take part. It will assess the effect of the weight loss drug on weight loss, diabetes, and other obesity-related complications.
Furthermore, the study will also analyse the impact of the weight loss injection on the participant’s employment status, including how many sick days they take.
Why is this study important?
There are several reasons why this weight loss study is important. One of the main reasons is that obesity costs the NHS approximately £6.5 billion a year and is the second largest preventable cause of cancer in the UK. More than a quarter of UK adults are living with obesity.
While research involving 26 European countries, found that obese individuals are more likely to take time off work because of health issues, and this increases with obesity severity.
Will the study have a lasting impact?
The results gathered from the five-year study will demonstrate the long-term impact of weight-loss injections from both a health and economic perspective.
If the results are positive, then it could pave the way for unemployed weight loss jabs to become the norm, or at least care pathways could be implemented to treat obesity.
What weight loss treatments are available currently?
The full impact of this study won’t be released for at least five years, so if you want to take control of your weight loss journey now, you can.
There are several weight loss treatment options already available for people with a BMI over 30 or between 27 and 30 if you have an obesity-related health problem, like diabetes or high blood pressure.
At Prescription Doctor, you can buy weight loss injections and weight loss pills directly from us. First, you’ll need to complete a short consultation with one of our clinicians so they can ensure your chosen treatment is safe and suitable for you. We will then deliver your treatment to your home address, promptly and discreetly.
Mounjaro
- Approved Weight Loss Treatment
- Suitable for adults with a BMI of +30kg/m²
- Pre-filled injection pen
Wegovy
- Approved Weight Loss treatment
- Weekly injection
- Reduces risk of heart attack & stroke
Alli (Orlistat)
- Available without a prescription
- Prevents absorption of fat
- Proven weight loss aid
What weight loss options do we offer?
At Prescription Doctor, you can choose from:
Weight loss injections
- Mounjaro: A prefilled injection pen that you self-inject once per week. It contains the active ingredient tirzepatide and can help you lose up to 26% of your initial body weight in 88 weeks. Zepbound also contains tirzepatide but it isn’t yet available in the UK.
- Wegovy: A once-weekly self-injectable weight loss pen that contains semaglutide. It works by mimicking a naturally occurring hormone called glucagon-like peptide-1 (GLP-1) to reduce your appetite and slow down digestion. Wegovy is a well-tolerated weight loss jab and can help you lose up to 15% of your body weight in one year.
- Saxenda: A daily weight loss injection pen that contains the active ingredient liraglutide.
Weight loss tablets
- Mysimba: A weight loss tablet that slowly releases its active ingredients over the day to reduce the risk of side effects and make it easier to increase your dose. Mysimba contains 2 active ingredients, naltrexone and bupropion, that act on the part of the brain responsible for appetite regulation.
- Xenical: Contains the active ingredient orlistat which stops up to a third of dietary fat being absorbed. Xenical can be taken up to 3 times a day.
- Alli: An over-the-counter version of orlistat that works in the same way as Xenical but only contains 60 mg of the active ingredient.
No matter what weight loss treatment you choose, they will be most effective when they are used alongside a diet and exercise plan. Grab 10% off any weight loss products from Prescription Doctor, just use ‘weg10’ at checkout.
Summary
With plans for a new five-year study investigating the effects of weight loss jabs on the unemployed, there has never been a better time to take care of your health and weight loss journey.
Get ahead of the trend and start your weight loss consultation with one of our clinicians today and grab 10% off - use code ‘weg10’ at checkout.
Sources
BBC News, (2024). Obese people take more sick days off work, study claims.
Department of Health and Social Care Media Centre, (2023). Accessing Wegovy for weight loss: Everything you need to know.
Department of Health and Social Care Media Centre, (2023). Obesity.
Additional Resources
Authored By
Leanne Edermaniger
Medical Content WriterPublished on: 23/10/2024
Reviewed By
Mohamed Imran Lakhi
MPharm - Lead PharmacistReviewed on: 23/10/2024
How We Are Regulated
Payment Options
© 2013 - 2025 Al Muhsineen Limited. All Rights Reserved. Registered Pharmacy: 34 Halliwell Road, Bolton BL1 8RL. Registered Office: 254 First Floor, Shearbrow, Blackburn, England, BB1 8DS
Patient Login
Don't have an account?
Your account will be automatically created after placing your first order.